Hypertriglyceridemia (free)

Hypertriglyceridemia Guidelines Endocrine Society

Hypertriglyceridemia Guidelines App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/118748

Contents of this Issue

Navigation

Page 2 of 5

Table 1. Causes of Hypertriglyceridemia Primary hypertriglyceridemia •  Familial combined hyperlipidemia •  Familial hypoalphalipoproteinemia •  Familial hypertriglyceridemia •  Familial chylomicronemia and related disorders •  Familial dysbetalipoproteinemia Primary genetic susceptibility •  Metabolic syndrome •  Treated type 2 diabetes Secondary hypertriglyceridemia •  Excess alcohol intake •  Renal disease •  Drug-induced (eg, thiazides, β-blockers, estrogens, isotretinoin, corticosteroids, bile acid-binding resins, antiretroviral protease inhibitors, immunosuppressants, antipsychotics) •  Liver disease •  Untreated diabetes mellitus •  Pregnancy •  Endocrine diseases •  Autoimmune disorders Table 2. Criteria Proposed for Clinical Diagnosis of Elevated Triglyceride Levels Under Fasting Conditions NCEP ATP III (3) The Endocrine Society 2010a Normal <150   mg/dL <1.7 mmol/ liter Normal <150   mg/dL <1.7 mmol/ liter Borderlinehigh triglycerides 150-199   mg/dL 1.7-2.3 mmol/liter Mild HTG 150-199   mg/dL 1.7-2.3 mmol/liter High triglycerides 200-499   mg/dL 2.3-5.6 mmol/liter Moderate HTG 200-999   mg/dL 2.3-11.2 mmol/liter Very high triglycerides ≥500   mg/dL ≥5.6 mmol/ liter Severe HTG 1000-1999 mg/dL 11.2-22.4 mmol/liter Very severe HTG ≥2000   mg/dL ≥22.4 mmol/liter a The criteria developed for the present guidelines focus on the ability to assess risk for premature CVD vs. risk for pancreatitis. The designations of mild and moderate hypertriglyceridemia correspond to the range of levels predominant in risk assessment for premature CVD, and this range includes the vast majority of subjects with hypertriglyceridemia. Severe hypertriglyceridemia carries a susceptibility for intermittent increases in levels above 2000 mg/dL and subsequent risk of pancreatitis; very severe hypertriglyceridemia is indicative of risk for pancreatitis. In addition, these levels suggest different etiologies. Presence of mild or moderate hypertriglyceridemia is commonly due to a dominant underlying cause in each patient, whereas severe or very severe hypertriglyceridemia is more likely due to several contributing factors.

Articles in this issue

Archives of this issue

view archives of Hypertriglyceridemia (free) - Hypertriglyceridemia Guidelines Endocrine Society